Gamble Jones Investment Counsel’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $515K | Hold |
4,040
| – | – | 0.04% | 147 |
|
|
2022
Q3 | $422K | Hold |
4,040
| – | – | 0.03% | 154 |
|
|
2022
Q2 | $424K | Sell |
4,040
-2,300
| -36% | -$273K | 0.03% | 156 |
|
|
2022
Q1 | $811K | Sell |
6,340
-190
| -3% | -$22.9K | 0.05% | 132 |
|
|
2021
Q4 | $805K | Hold |
6,530
| – | – | 0.05% | 131 |
|
|
2021
Q3 | $928K | Sell |
6,530
-206
| -3% | -$30.3K | 0.06% | 123 |
|
|
2021
Q2 | $1.05M | Hold |
6,736
| – | – | 0.07% | 120 |
|
|
2021
Q1 | $1.05M | Hold |
6,736
| – | – | 0.07% | 122 |
|
|
2020
Q4 | $1.01M | Sell |
6,736
-16
| -0.2% | -$2.26K | 0.07% | 119 |
|
|
2020
Q3 | $892K | Buy |
6,752
+16
| +0.2% | +$2.09K | 0.06% | 122 |
|
|
2020
Q2 | $781K | Hold |
6,736
| – | – | 0.06% | 123 |
|
|
2020
Q1 | $661K | Sell |
6,736
-840
| -11% | -$110K | 0.06% | 125 |
|
|
2019
Q4 | $1.1M | Hold |
7,576
| – | – | 0.09% | 121 |
|
|
2019
Q3 | $1.01M | Sell |
7,576
-507
| -6% | -$65.5K | 0.08% | 119 |
|
|
2019
Q2 | $924K | Buy |
8,083
+1,270
| +19% | +$149K | 0.08% | 125 |
|
|
2019
Q1 | $845K | Hold |
6,813
| – | – | 0.07% | 126 |
|
|
2018
Q4 | $686K | Sell |
6,813
-2,153
| -24% | -$242K | 0.07% | 132 |
|
|
2018
Q3 | $1.14M | Hold |
8,966
| – | – | 0.11% | 119 |
|
|
2018
Q2 | $970K | Sell |
8,966
-556
| -6% | -$60.5K | 0.1% | 121 |
|
|
2018
Q1 | $1.01M | Hold |
9,522
| – | – | 0.1% | 122 |
|
|
2017
Q4 | $1.12M | Hold |
9,522
| – | – | 0.11% | 116 |
|
|
2017
Q3 | $1.08M | Hold |
9,522
| – | – | 0.11% | 115 |
|
|
2017
Q2 | $1.19M | Hold |
9,522
| – | – | 0.12% | 114 |
|
|
2017
Q1 | $1.13M | Hold |
9,522
| – | – | 0.12% | 118 |
|
|
2016
Q4 | $954K | Hold |
9,522
| – | – | 0.11% | 124 |
|
|
2016
Q3 | $1.2M | Hold |
9,522
| – | – | 0.13% | 111 |
|
|
2016
Q2 | $1.11M | Hold |
9,522
| – | – | 0.12% | 115 |
|
|
2016
Q1 | $986K | Sell |
9,522
-217
| -2% | -$21K | 0.11% | 118 |
|
|
2015
Q4 | $970K | Hold |
9,739
| – | – | 0.11% | 120 |
|
|
2015
Q3 | $888K | Sell |
9,739
-2,369
| -20% | -$237K | 0.1% | 127 |
|
|
2015
Q2 | $1.33M | Sell |
12,108
-89
| -0.7% | -$9.85K | 0.14% | 112 |
|
|
2015
Q1 | $1.39M | Sell |
12,197
-245
| -2% | -$28K | 0.14% | 111 |
|
|
2014
Q4 | $1.37M | Buy |
12,442
+334
| +3% | +$35.2K | 0.14% | 107 |
|
|
2014
Q3 | $1.18M | Sell |
12,108
-118
| -1% | -$11.6K | 0.13% | 111 |
|
|
2014
Q2 | $1.23M | Sell |
12,226
-103
| -0.8% | -$10.1K | 0.14% | 111 |
|
|
2014
Q1 | $1.13M | Sell |
12,329
-541
| -4% | -$49.9K | 0.13% | 110 |
|
|
2013
Q4 | $1.16M | Buy |
12,870
+29
| +0.2% | +$2.51K | 0.14% | 106 |
|
|
2013
Q3 | $1.02M | Hold |
12,841
| – | – | 0.13% | 111 |
|
|
2013
Q2 | $934K | Buy |
+12,841
| New | +$960K | 0.12% | 113 |
|
Other funds holding ZBH
Gamble Jones Investment Counsel's ZBH Position: Q4 2022 in Review
Gamble Jones Investment Counsel held its Zimmer Biomet (ZBH) position steady in Q4 2022 at 4,040 shares worth $515K. The position accounts for 0.04% of the portfolio, ranked #147.
Gamble Jones Investment Counsel first reported a position in ZBH in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.39M in Q1 2015. 978 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.
- Gamble Jones Investment Counsel held 4,040 shares of Zimmer Biomet worth $515K as of Q4 2022.
- Gamble Jones Investment Counsel left its Zimmer Biomet share count unchanged in Q4 2022.
- Zimmer Biomet made up 0.04% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #147 holding.
- Gamble Jones Investment Counsel first reported a position in Zimmer Biomet in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Zimmer Biomet position peaked at $1.39M in Q1 2015.
- 978 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.